. lonophoretic application of NAAG onto pyramidal cells in stratum radiatum of the hippocampus (Bernstein et al., 1985) or on pyramidal cells in the prepyriform cortex receiving excitatory innervation from the lateral olfactory tract (LOT) results in excitation (ffrench-Mullen et al., 1985). Similar to the endogenous neurotransmitter released by the LOT, but in contrast to L-glutamate itself, the excitatory effects of NAAG are antagonized by o,&amino-4-phosphonobutyric acid (APB). In addition, the excitatory effects of NAAG are not antagonized by 2-amino&phosphonovaleric acid (APV), which has relatively high specificity for blocking receptors activated by N-methyl-D-aspartic acid (NMDA) (J. gand-binding studies, Watkins and Evans (1981) and, more recently, Foster and Faag (1984) have distinguished several excitatory amino acid receptors; these include the NMDA receptor, the kainate receptor, and the quisqualate receptor. A fourth receptor has been described on the basis of the observation that L-APB selectively blocks synaptic transmission at sites that are not affected by NMDA receptor antagonists and at concentrations that do not affect the excitation induced by kainate or quisqualate. On the basis of ligandbinding studies, Foster and Fagg (1984) have designated this site as the "A-4" receptor, which binds [3H]APB, exhibits chloride dependence, and is activated by calcium.
tissues. Within the central nervous system, the thalamus exhibited the greatest amount of binding, whereas binding was lowest in cortex. Calcium ions enhanced the specific binding, whereas sodium ions caused a concentration-dependent inhibition. These results suggest that [3H]NAAG labels an acidic amino acid receptor site designated "A-4," which recognizes the antagonist, 2-amino-4-phosphonobutyric acid, and that this receptor may mediate the neurophysiologic effects of endogenous NAAG.
N-Acetylaspartylglutamate
(NAAG) is an acidic peptide found in brain that exhibits high affinity for a subpopulation of brain receptor sites labeled with [3H]-L-glutamate (Zaczek et al., 1983; Keller and Coyle, 1984a) . lonophoretic application of NAAG onto pyramidal cells in stratum radiatum of the hippocampus (Bernstein et al., 1985) or on pyramidal cells in the prepyriform cortex receiving excitatory innervation from the lateral olfactory tract (LOT) results in excitation (ffrench-Mullen et al., 1985) . Similar to the endogenous neurotransmitter released by the LOT, but in contrast to L-glutamate itself, the excitatory effects of NAAG are antagonized by o,&amino-4-phosphonobutyric acid (APB). In addition, the excitatory effects of NAAG are not antagonized by 2-amino&phosphonovaleric acid (APV), which has relatively high specificity for blocking receptors activated by N-methyl-D-aspartic acid (NMDA) (J. M. H. ffrench-Mullen, K. J. Keller, R. Zaczek, J. T. Coyle, N. Hori, and D. 0. Carpenter, unpublished observation) .
On the basis of neurophysiologic, neuropharmacologic, and li-gand-binding studies, Watkins and Evans (1981) and, more recently, Foster and Faag (1984) have distinguished several excitatory amino acid receptors; these include the NMDA receptor, the kainate receptor, and the quisqualate receptor. A fourth receptor has been described on the basis of the observation that L-APB selectively blocks synaptic transmission at sites that are not affected by NMDA receptor antagonists and at concentrations that do not affect the excitation induced by kainate or quisqualate. On the basis of ligandbinding studies, Foster and Fagg (1984) have designated this site as the "A-4" receptor, which binds [3H]APB, exhibits chloride dependence, and is activated by calcium. The results from displacement studies with NAAG for the specific binding of [3H]-L-glutamate are consistent with NAAG interacting with an excitatory receptor subpopulation that is chloride dependent and activated by calcium (Koller and Coyle, 1984a) . Furthermore, the neurophysiologic studies suggest that APB is a selective antagonist of NAAG-induced excitation (ffrench-Mullen et al., 1985) . With the recent availability of [3H]NAAG at high specific radioactivity, it is now possible to characterize directly the recognition sites with which it interacts. In a preliminary communication, we demonstrated that [3H]NAAG binds with a high degree of specificity to a single population of noninteracting recognition sites in rat brain membranes (Keller and Coyle, 1984b) . In the present paper, we have provided a detailed evaluation of the conditions for and kinetics of the specific binding of [3H]NAAG and present evidence that this endogenous peptide may label the "A-4" excitatory receptor subtype.
Materials and Methods

Materials
Albino Sprague-Dawley rats (100 to 150 gm) were used in all experiments (Harlan-Sprague Dawley, Indianapolls, IN). Aspartylglutamate was a gift from K. Biziere of Clrnr-Mrdr, Montpellier, France, and cold NAAG was synthesized from this as prevrously described (Koller et al., 1984) . The identity of NAAG was verified by amino acid analysis and by fast atom bombardment mass spectroscopy (Zaczek et al., 1983 Rat forebrain was removed from adult male albino Sprague-Dawley rats and homogenized in 10 vol of ice-cold 0.32 M sucrose. After centrifugation at 1,000 x g for 10 mm to remove nuclei, the supernatant was centrrfuged at 18,000 x g for 20 min to isolate a crude synaptosomal preparation (P?). The PZ fractron was resuspended in 10 vol of drstilled Hz0 with a Polytron (setting 6g, 30 set) and centrifuged at 7,500 x g for 20 min.
The supernatant and buffy coat were removed and diluted wrth 5 ml of 50 mM Trrs-HCI, pH 7.2, and the suspensron was centrifuged at 40,000 x g for IO min. The supernatant fluid was discarded and the pellet was frozen at -80°C for future use. The frozen pellet was sonrcated in 15 vol of 50 mM Trrs-HCI, pH 7.2, and preincubated for 30 mm at 37°C. Followrng centrifugation at 40,000 X g for 10 min, the pellet was washed two more times in 15 vol of buffer each trme. The final pellet was resuspended in buffer such that 0.2 ml contained 100 to 140 pg of protern. Protein was measured by the method of Lowry et al. (1951) .
For developmental studres, four pups were sacrificed at each time point (days of age: 2, 8, 14, 21, 28, and 35) from four different litters, and the whole brain, including olfactory bulbs, was prepared as above. The regional study was carried out on tissue from adult male Sprague-Dawley rats dissected by the method of Glowinski and lversen (1966 Each filter was washed with 15 ml of 50 mM Tris-HCI, pH 7.2, at 37°C and radioactivity was measured by scintrllatron spectrometry in a Beckman LS 2800 scintillation counter after solubilrzrng the filters in 10 ml of Formula 947 (New England Nuclear).
Results
Effects of assay conditions on the specific binding of PH]NAAG. reversible since the addition of an excess of L-glutamate after equilibrium was reached resulted in a rapid decrease in [3H]NAAG specifically bound. Displacement curves of the specific binding of 2 nM [3H]NAAG were generated for a variety of substances reputed to act as agonists or antagonists at glutamate receptors or analogues of NAAG. As shown in Figure 4 , unlabeled NAAG, L-glutamate, and APB exhibited parallel displacement curves with NAAG having approximately 3-fold greater affinity than L-glutamate and APB being approximately 10 times less potent than L-glutamate. All three displacers exhibited Hill coefficients of approximately 1 .O, consistent with their interaction at a single population of noninteracting sites.
Pharmacology. Displacement of [3H]NAAG by various compounds was studied and their K, values are listed in Table III . Notably, the site labeled by [3H]NAAG exhibited stereospecificity since o-Glu was nearly 10 times less potent than L-glutamate and, although Laspartate exhibited a K, of 3 PM, D-aspartate was ineffective at the site. Of the peptides studied (all L-isomers with Lu-peptide bonds), those enriched in acidic amino acids were active at the site. Specifically, Glu-Glu and Asp-Glu were very potent, whereas Glu-Asp, AspAsp, N-acety-Glu-Asp and VaCGly-Asp-Glu, a chemotactic substance, all interacted with the site to a much lower degree. In addition, a large number of sulfur-containing compounds were recognized by this site. Notably, serine-o-sulfate was the most potent compound studied. L-Cysteine, o-homocysteic acid, L-cysteic acid, and L-cysteinesulfonic acid also displace [3H]NAAG. Both quisqualate and ibotenate were potent in their interaction with K,'s in the nanomolar range. Finally, the amino-phosphono analogues were also active at NAAG with or without 0.5 mM L-glutamate.
The assay was terminated at various times and the total amount bound was determined.
After equilibrium, a large excess of L-glutamate was added (at arrow), and at various times, the assay was terminated and the amount of [3H]NAAG specIfIcally bound was determined.
The results are the mean of two experiments with triplicate this site. APB was the most potent (K, = 3.86 PM), and both APV and o,L-2-amino-7-phosphonoheptanoic acid (APH) displaced with K,s of 6 and 11.4 FM, respectively.
Table IV lists the compounds tested with K, values greater than 0.1 mM. Among these substances are amino acids such as GABA, glycine, N-acetylaspartate, and glutamate diethylester. A variety of aspartyl-peptides were inactive, as was the neuronal tripeptide, thyrotropin-releasing hormone. Of the excitatory amino acid analogues tested, NMDA, kainate, and quinolinic acid were also ineffective. In addition, 2-amino-3-phosphonopropionate was the only amino-phosphono analogue tested that was ineffective. Regional and peripheral distribution of specifically bound rH] NAAG. The regional distribution of [3H]NAAG binding was examined in seven regions of the brain as well as in spinal cord (Table V) . Thalamus exhibited the greatest amount of binding at 2 nM (210 + 25 fmol/mg of protein), and spinal cord had the next highest amount (203 + 13 fmol/mg of protein). Cortex had substantially lower specific binding (132 f 14 fmol/mg of protein), being only 63% of the level in thalamus. No significant binding of NAAG was seen in the peripheral tissues studied (Table VI) . The amount of specific binding in heart, liver, kidney, spleen, and lung ranged from -0.8% to 1.4% of the amount seen in the thalamus. Notably, no specific binding was seen in the intestine, an area where many other neuronal peptides are active. /on effects. As demonstrated in Table II 
Peptrdes
Excitatory Amino Acid Analogues Coyle, 1977) . (Bernstein et al., 1985; ffrench-Mullen et al., 1985 In the LOT, which has been considered an aspartergicl glutamatergic pathway (Harvey et al., 1975; Bradford and Richards, 1976; Collins, 1978) only the effects of NAAG and the endogenous neurotransmitter are blocked by the antagonist, APB, whereas the excitatory effect of glutamate is insensitive to this concentration of APB (ffrench-Mullen et al., 1985 
